SAB Biotherapeutics prices $85M stock offering at $3.85/share

AI Briefing

• – SAB Biotherapeutics raises $85 million in a stock offering at $3.85 per share.
• – The company will use the funds for general corporate purposes.
• – This is SAB Biotherapeutics' first public stock offering.